You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

chronic hepatitis C virus genotype 2

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Hepatitis C Virus (HCV) Infection Trial (ABT-493/ABT-530, Placebo for ABT-493/ABT-530)

Completed
Has Results
  • Chronic Hepatitis C Virus (HCV) Infection
  • (no location specified)
Jul 14, 2021

Chronic Hepatitis C Virus, Hepatitis C Virus Trial (ABT-493/ABT-530, sofosbuvir (SOF), ribavirin (RBV))

Completed
Has Results
  • Chronic Hepatitis C Virus
  • Hepatitis C Virus
  • (no location specified)
Jul 14, 2021

Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C Trial (ABT-493 coformulated with

Completed
Has Results
  • Hepatitis C Virus Infection
  • +3 more
  • ABT-493 coformulated with ABT-530
  • (no location specified)
Jul 9, 2021

Hepatitis C Virus Infection, Chronic Hepatitis C, Compensated Cirrhosis Trial (ABT-493/ABT-530)

Completed
Has Results
  • Hepatitis C Virus Infection
  • +2 more
  • (no location specified)
Jul 9, 2021

Chronic Hepatitis C Virus Infection Trial (OBV/PTV/r, Sofosbuvir, Ribavirin (RBV))

Completed
Has Results
  • Chronic Hepatitis C Virus Infection
  • (no location specified)
Jul 8, 2021

Chronic Hepatitis C, HCV, Hepatitis C Virus Trial (glecaprevir/pibrentasvir)

Completed
Has Results
  • Chronic Hepatitis C
  • +2 more
  • (no location specified)
Jul 9, 2021

Hepatitis C Virus Trial (ABT-450/r/ABT-267, Ribavirin)

Completed
Has Results
  • Hepatitis C Virus
  • (no location specified)
Jul 28, 2021

HCV, Hepatitis C Infection, Genotype 4 Trial (2 DAA, RBV)

Completed
Has Results
  • HCV
  • +2 more
  • (no location specified)
Jul 28, 2021

Oral Glecaprevir/Pibrentasvir Tablets in Participants Aged 12

Active, not recruiting
  • Hepatitis C Virus (HCV)
    • Chelyabinsk, Russian Federation
    • +9 more
    Mar 1, 2022

    Hepatitis C, Chronic Trial in Taiwan (PEGASYS 180 µg Q1W, P1101 180 µg Q1W, 48 doses, P1101 270µg Q1W, 48 doses)

    Completed
    • Hepatitis C, Chronic
    • PEGASYS 180 µg Q1W
    • +3 more
    • Changhua, Taiwan
    • +12 more
    Oct 7, 2021

    Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/Pibrentasvir)

    Completed
    Has Results
    • Hepatitis C Virus (HCV)
    • San Diego, California
    • +24 more
    Jul 14, 2021

    Chronic Hepatitis c Genotype 1 Trial in Moscow, Saint Petersburg (Narlaprevir, Ritonavir, Sofosbuvir)

    Completed
    • Chronic Hepatitis c Genotype 1
    • Moscow, Russian Federation
    • +4 more
    Oct 27, 2022

    Seroconversion of Hepatitis c Virus Among CKD on Regular

    Not yet recruiting
    • Hepatitis C Virus
      • (no location specified)
      Oct 25, 2023

      Hepatitis C, Chronic Trial in Carlsbad (ISIS 14803)

      Completed
      • Hepatitis C, Chronic
      • ISIS 14803
      • Carlsbad, California
        Isis Pharmaceuticals
      Dec 1, 2022

      Occult Hepatitis C Virus Infection in Patients Born Before 1969

      Not yet recruiting
      • Hepatitis C, Chronic
      • +2 more
      • Meridan Bioscience Point of Care test against HCV antibodies
      • (no location specified)
      Apr 2, 2023

      Chronic Hepatitis C Virus Infection Trial in China, Korea, Republic of, Taiwan (P1101 + Ribavirin, PEG-Intron + Ribavirin)

      Completed
      • Chronic Hepatitis C Virus Infection
      • P1101 + Ribavirin
      • PEG-Intron + Ribavirin
      • Beijing, China
      • +38 more
      Jan 14, 2022

      Chronic Hepatitis C, Hepatitis C Virus, Genotype 3 Hepatitis C Virus Trial (ABT-493/ABT-530, Sofosbuvir, Daclatasvir)

      Completed
      Has Results
      • Chronic Hepatitis C
      • +2 more
      • (no location specified)
      Jul 9, 2021

      Chronic Hepatitis C Virus, Hepatitis C, Chronic, Hepatitis C Trial in Bucuresti (Bemnifosbuvir, Ruzasvir)

      Recruiting
      • Chronic Hepatitis C Virus
      • +4 more
      • Bucuresti, BUC, Romania
        Atea Study Site
      Jun 15, 2023

      Hepatitis C Trial in Bradford, London, Nottingham (Telaprevir, 40 Kd Pegylated interferon alfa 2a, Ribavirin)

      Completed
      • Hepatitis C
      • Bradford, United Kingdom
      • +3 more
      Jan 4, 2023

      Hepatitis C, HCV Trial in San Antonio (TD-6450, Placebo)

      Completed
      • Hepatitis C
      • HCV
      • San Antonio, Texas
        Texas Liver Institute
      Jan 15, 2021

      Liver Cancer Trial in Houston (Bevacizumab, Atezolizumab, Sofosbuvir)

      Not yet recruiting
      • Liver Cancer
      • Houston, Texas
        M D Anderson Cancer Center
      Feb 9, 2023

      Hepatitis C Virus Trial (ABT-493/ABT-530)

      Completed
      Has Results
      • Hepatitis C Virus
      • (no location specified)
      Jul 9, 2021

      Determine Hepatitis C Virus Infection Prevalence Among Patients

      Completed
      • Chronic Hepatitis c
      • Vasculitis
        • Mexico City, Mexico
          Hospital General de Mexico
        Mar 15, 2022

        Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (Ombitasvir/Paritaprevir/Ritonavir, Dasabuvir)

        Completed
        Has Results
        • Chronic Hepatitis C Infection
        • Compensated Cirrhosis
        • (no location specified)
        Jul 8, 2021

        Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493/ABT-530)

        Completed
        Has Results
        • Chronic Hepatitis C
        • +2 more
        • (no location specified)
        Jul 9, 2021